Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy)

dc.contributor.authorCumurcu, Tongabay
dc.contributor.authorCumurcu, Birgül Elbozan
dc.contributor.authorZayman, Esra Porgalı
dc.contributor.authorÇavdar, Müfide
dc.contributor.authorNurlu, Kayhan
dc.contributor.authorDoğanay, Selim
dc.date.accessioned2020-05-27T18:15:01Z
dc.date.available2020-05-27T18:15:01Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.descriptionÖz:A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes. Başlık (Türkçe):Muhtemel Sertraline Bağlı Santral Seroz Retinopati Öz (Türkçe):en_US
dc.description.abstractÖz: A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes. Başlık (Türkçe): Muhtemel Sertraline Bağlı Santral Seroz Retinopati Öz (Türkçe):en_US
dc.identifier.citationTongabay C., Birgül ELBOZAN C., Esra PORGALI Z., Müfide Ç., Kayhan N., Selim D. (2017). Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy), Retina-Vitreus, İnönü Üniversitesi, Malatya.en_US
dc.identifier.endpage271en_US
dc.identifier.issn1300-1256
dc.identifier.issn2717-7149
dc.identifier.startpage269en_US
dc.identifier.trdizinid296698en_US
dc.identifier.urihttps://hdl.handle.net/11616/15598
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/296698
dc.identifier.volume26en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isotren_US
dc.publisherRetina-Vitreusen_US
dc.relation.ispartofRetina-Vitreusen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGöz Hastalıklarıen_US
dc.titlePresumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy)en_US
dc.title.alternativeMuhtemel Sertraline Bağlı Santral Seroz Retinopatien_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Yeni Microsoft Word Belgesi.docx
Boyut:
19.99 KB
Biçim:
Microsoft Word XML
Açıklama:
Makale Dosyası
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: